Journal of the American Society of Nephrology· 2017Q1

Antibody-Mediated Rejection Due to Preexisting versus De Novo Donor-Specific Antibodies in Kidney Allograft Recipients

Olivier Aubert, Alexandre Loupy, Luis Hidalgo, Jean–Paul Duong Van Huyen et al.

251citations
Q1SCImago
2017year

Short summary

Kidney transplant recipients with de novo donor-specific antibodies (DSA) at rejection show worse graft survival (34% at 8 years) compared to those with preexisting DSA (63%), despite similar C4d deposition and peritubular capillaritis.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Transplantation

TransplantationMedicine